(unprocessed)
TITLE: ASCO26: RevMed’s daraxonrasib presents a turning point for pancreatic cancer SOURCE: Pharmaceutical Technology DESCRIPTION: <a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxQMnpzYXI4VWdTUWF2NkpWOWVCLUJOcW5TV00xUkt6Z0hqWGptbjVVQXVxM3FtZkVLWVQyenpocmxqcmdVZEJVWUpORFZkeENtdzQxR0l3RlFLeHJ3ZlFyeXNJQm5LM0I3ZEp1T3AtejRJN25zX1o1eFp4MktybmRHVFNXWjlVeDhZdnNHM2ZjekJoWkJiTGVPYl8zZ19zbDdvQUl4blBrZ3dTVEtLcVpnbjRBQXhIRFpSWFo3a0tPeW9FdTVtbHJ3eU1uODVBZw?oc=5" target="_blank">ASCO26: RevMed’s daraxonrasib presents a turning point for pancreatic cancer</a> <font color="#6f6f6f">Pharmaceutical Technology</font>
{
"summary": "",
"topics": [],
"entities": {
"people": [],
"places": [],
"orgs": []
},
"dates": [],
"action_items": [],
"sentiment": "neutral",
"category": "other",
"tags": [],
"title": "ASCO26: RevMed’s daraxonrasib presents a turning point for pancreatic cancer",
"url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQMnpzYXI4VWdTUWF2NkpWOWVCLUJOcW5TV00xUkt6Z0hqWGptbjVVQXVxM3FtZkVLWVQyenpocmxqcmdVZEJVWUpORFZkeENtdzQxR0l3RlFLeHJ3ZlFyeXNJQm5LM0I3ZEp1T3AtejRJN25zX1o1eFp4MktybmRHVFNXWjlVeDhZdnNHM2ZjekJoWkJiTGVPYl8zZ19zbDdvQUl4blBrZ3dTVEtLcVpnbjRBQXhIRFpSWFo3a0tPeW9FdTVtbHJ3eU1uODVBZw?oc=5"
}